National Cancer Institute; Notice of Meeting

Issuing agencies

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 192 (Tuesday, October 6, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 192 (Tuesday, October 6, 2026)]
[Notices]
[Pages 63569-63570]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-20424]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the President's Cancer 
Panel.

[[Page 63570]]

    The meeting will be held as a virtual meeting and will be open to 
the public as indicated below. Individuals who plan to view the virtual 
meeting and need special assistance or other reasonable accommodations 
to view the meeting, should notify the Contact Person listed below in 
advance of the meeting. The meeting can be accessed by clicking on the 
links below.

    Name of Committee: President's Cancer Panel.
    Date: October 15, 2026.
    Time: 9:00 a.m. to 1:00 p.m.
    Agenda: Opportunities to Reduce Obesity-Related Cancer Risk: 
GLP-1 Medications.
    Address: National Institutes of Health, 31 Center Drive, Room 
11A30B, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting. Access to Meeting: <a href="https://cbiit.webex.com/weblink/register/r8def1cffd7e6e17a9b599f8f3c6e9441">https://cbiit.webex.com/weblink/register/r8def1cffd7e6e17a9b599f8f3c6e9441</a>.
     Contact Person: Samantha L. Finstad, Ph.D., Executive 
Secretary, President's Cancer Panel, Office of the Director, 
National Cancer Institute, NIH, 31 Center Drive, Room 11A30B, MSC 
2590, Bethesda, MD 20892, 240-276-6460, <a href="/cdn-cgi/l/email-protection#5a293b373b342e323b743c3334292e3b3e1a343332743d352c"><span class="__cf_email__" data-cfemail="55263438343b213d347b333c3b26213431153b3c3d7b323a23">[email&#160;protected]</span></a>.

    Registration is not required to attend this meeting.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the PCP website: <a href="https://prescancerpanel.cancer.gov/">https://prescancerpanel.cancer.gov/</a>, where an agenda, instructions for 
accessing the virtual meeting, and any additional information for 
the meeting will be posted when available.


(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: October 1, 2026.
Kuleni D. Onnen,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2026-20424 Filed 10-5-26; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>